Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis.
It is still uncertain which, if any, immunologic parameters may help diagnose a renal flare of lupus nephritis. Anti-C1q antibody (Ab) titers have been elevated in patients with lupus with renal involvement, but little information is available on whether the titers are different in quiescent and active phases of lupus nephritis. In this study, we compared anti-C1q Ab titers with other serological test results in 48 patients with biopsy-proven lupus nephritis to assess which parameter could offer the best reliability for differentiating between quiescent and active phases of lupus nephritis. Serum C3 and C4 levels, as well as anti-double-stranded DNA, antiendothelial cell, anti-C1q, and antiphospholipid Ab titers, were evaluated in patients with quiescent renal disease (38 samples) and those with clinical evidence of renal activity (23 samples). Only anti-C1q Ab titers correlated with active renal disease in both univariate (P < 0.0001) and multivariate analysis (P < 0.0001), with a sensitivity of 87% and a specificity of 92%. In six patients, immunologic parameters were measured serially. In all patients, the high anti-C1q Ab titers returned to normal values after treatment-induced remission. The other serological parameters did not show a significant association with renal disease activity. In patients with biopsy-proven lupus nephritis, anti-C1q Ab titers appear to be strongly related to renal disease activity. Their measurement may be useful for confirming the diagnosis of renal flares of lupus nephritis.
Divisione di Nefrologia e Dialisi and III Divisione Medicina, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, degli Studi di Pavia, Italy.
G
G
Moroni
M
M
Trendelenburg
N
N
Del Papa
S
S
Quaglini
E
E
Raschi
P
P
Panzeri
C
C
Testoni
A
A
Tincani
G
G
Banfi
G
G
Balestrieri
J A
JA
Schifferli
P L
PL
Meroni
C
C
Ponticelli
D000328:Adult; D000704:Analysis of Variance; D000906:Antibodies / Q000276:immunology; D017152:Antibodies, Antiphospholipid / Q000097:blood; D015922:Complement C1q / Q000032:analysis* / Q000276:immunology; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D004247:DNA / Q000097:blood; D018450:Disease Progression; D004727:Endothelium / Q000166:cytology / Q000276:immunology; D005260:Female; D006801:Humans; D008181:Lupus Nephritis / Q000175:diagnosis* / Q000276:immunology; D008297:Male; D012044:Regression Analysis; D012680:Sensitivity and Specificity
D000906:Antibodies; D017152:Antibodies, Antiphospholipid; D003176:Complement C3; D003181:Complement C4; D015922:Complement C1q; D004247:DNA